Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-29

Clinical Trial Update: Comparison Of The Effect Of Propolis And Gluma Desensitizer On The Management Of Dentin Hypersensitivity [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial comparing propolis and Gluma desensitizer for dentin hypersensitivity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gluma Desensitizer (glutaraldehyde/HEMA desensitizer)
  • Propolis (propolis)

Snippet

Sponsor: Dow University of Health Sciences | Conditions: Dentin Hypersensitivity | Phase 2, Phase 3 | Status: COMPLETED